Edit
Cancer genomics – Course and Conference Office

EMBL Conference

Cancer genomics

Overview

EMBL is committed to sharing research advances and sustaining scientific interaction throughout the coronavirus pandemic. We are delighted to announce that this conference is going virtual and invite you to join us online.

Conference Overview

This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer immunogenomics and epigenomics, cancer mouse models and the translation and clinical impact of obtained scientific results. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

Session Topics

  • Mutation and clonal selection in normal tissues
  • Genomic instability and mutational processes
  • Cancer evolution and drivers
  • Emerging technologies in cancer genomics
  • Cancer ecosystems, microenvironment and immunogenomics
  • Cancer genome medicine

What past participants say about the conference:

EMBL provided a wonderful opportunity for the exchange and application of new ideas within the OMICs cancer research. A great conference!” – Angelica Boldt, Postgraduate Program in Genetics, Department of Genetics, Federal University of Paraná (UFPR), Argentina

This is the third time I have attended this conference. I keep coming back because of the quality of work presented, the expectation that presenters discuss their latest findings and the meeting having the optimal number of attendees.” – Sean Grimmond, University of Melbourne, Australia

Date: 22 - 24 Nov 2021

Location: Virtual


Deadline(s):

Abstract submission: Closed

Registration: Closed


Organisers:

  • Jan Korbel
    EMBL Heidelberg, Germany
    • Núria López-Bigas
      Institute for Research in Biomedicine, Spain

Edit